高级检索
当前位置: 首页 > 详情页

A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)

文献详情

资源类型:
WOS体系:

收录情况: ◇ SCIE

单位: [1]Shanghai Chest Hosp, Shanghai, Peoples R China [2]Harbin Med Univ, Affiliated Canc Hosp, Harbin, Heilongjiang, Peoples R China [3]Jinnan Cent Hosp, Jinan, Shandong, Peoples R China [4]Xuzhou Cent Hosp, Xuzhou, Jiangsu, Peoples R China [5]Fudan Univ, Shanghai Canc Ctr, Med Oncol, Shanghai, Peoples R China [6]Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China [7]Anhui Med Univ, Hosp 2, Hefei, Anhui, Peoples R China [8]Xiamen Univ, Affiliated Hosp 1, Xiamen, Fujian, Peoples R China [9]Nantong Tumor Hosp, Nantong, Peoples R China [10]Linyi Canc Hosp, Linyi, Shandong, Peoples R China [11]Guangzhou Med Univ, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China [12]Peoples Liberat Army, Hosp 307, Beijing, Peoples R China [13]Zhejiang Canc Hosp, Hangzhou, Zhejiang, Peoples R China [14]Jiangxi Canc Hosp, Nanchang, Jiangxi, Peoples R China [15]Beijing Canc Hosp, Beijing, Peoples R China [16]Jilin Canc Hosp, Changchun, Jilin, Peoples R China [17]Cent S Univ, Xiangya Hosp 2, Changsha, Hunan, Peoples R China [18]Jiangyin Peoples Hosp, Jiangyin, Peoples R China [19]Hubei Canc Hosp, Wuhan, Hubei, Peoples R China [20]Sichuan Univ, West China Hosp, Chengdu, Sichuan, Peoples R China [21]Xinjiang Canc Hosp, Urumqi, Peoples R China [22]Guangdong Med Univ, Affiliated Hosp, Guangzhou, Guangdong, Peoples R China [23]Chinese Peoples Liberat Army, Gen Hosp Eastern War Zone, Nanjing, Jiangsu, Peoples R China [24]First Hosp Jilin Univ, Changchun, Jilin, Peoples R China [25]Shanghai Changhai Hosp, Shanghai, Peoples R China [26]Northern Jiangsu Peoples Hosp, Yangzhou, Jiangsu, Peoples R China [27]Liaoning Canc Hosp, Shenyang, Liaoning, Peoples R China [28]Northern Theater Command, Gen Hosp, Shenyang, Liaoning, Peoples R China [29]Ningxia Med Univ, Gen Hosp, Yinchuan, Peoples R China [30]Fifth Peoples Hosp Shanghai, Shanghai, Peoples R China [31]Anhui Prov Hosp, Hefei, Anhui, Peoples R China [32]Southern Med Univ, Nanfang Hosp, Guangzhou, Guangdong, Peoples R China [33]Zhe Jiang Univ, Sch Med, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China [34]Guangxi Med Univ, Affiliated Hosp 4, Liuzhou, Peoples R China [35]Hust, Tongji Med Coll, Tongji Hosp, Wuhan, Hubei, Peoples R China [36]Guandong Prov Peoples Hosp, Guangzhou, Guangdong, Peoples R China [37]Nanjing Chinese Med Univ, Affiliated Bayi Hosp, Nanjing, Jiangsu, Peoples R China [38]Hangzhou First Peoples Hosp, Hangzhou, Zhejiang, Peoples R China [39]Peking Univ, Hosp 3, Beijing, Peoples R China [40]Capital Med Univ, Beijing Chest Hosp, Beijing, Peoples R China [41]Zhejiang Univ, Affiliated Hosp 1, Hangzhou, Zhejiang, Peoples R China [42]Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China [43]Hainan Gen Hosp, Haikou, Hainan, Peoples R China [44]Nanchang Univ, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China [45]Yunnan Canc Hosp, Kunming, Yunnan, Peoples R China [46]Hutchison Medi Pharma, Shanghai, Peoples R China
出处:
ISSN:

关键词: Fruquintinib advanced NSCLC Vascular Endothelial Growth Factor Receptor

语种:
被引次数:
WOS:
中科院(CAS)分区:
出版当年[2018]版:
大类 | 1 区 医学
小类 | 2 区 肿瘤学 2 区 呼吸系统
最新[2025]版:
大类 | 1 区 医学
小类 | 1 区 肿瘤学 1 区 呼吸系统
JCR分区:
出版当年[2017]版:
Q1 RESPIRATORY SYSTEM Q1 ONCOLOGY
最新[2023]版:
Q1 ONCOLOGY Q1 RESPIRATORY SYSTEM

影响因子: 最新[2023版] 最新五年平均 出版当年[2017版] 出版当年五年平均 出版前一年[2016版] 出版后一年[2018版]

第一作者:
第一作者单位: [1]Shanghai Chest Hosp, Shanghai, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:426 今日访问量:0 总访问量:408 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)